The main growth driver for Alkermes going forward will be ALKS 2680. Read why I maintain my buy rating on ALKS stock.

Various medications that treat narcolepsy are available, and treatment plans can vary based on individual symptoms and other ...

People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...

Narcolepsy is now treated symptomatically ... A more suitable and effective treatment strategy may therefore be to supplement hypocretin transmission, for example, using hypocretin receptor ...

Find effective medications for 'Narcolepsy treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...

Treatments for narcolepsy center on getting rid of or reducing symptoms. Treatment approaches include behavioral changes and using prescription medications. Insomnia is a common sleep disorder ...

An expert discusses the significance of low-sodium oxybate for patients with narcolepsy patients with and cardiovascular disease and compares the diagnostic criteria and clinical presentations of ...

Axsome Therapeutics AXSM announced that it has entered into a settlement agreement with Hikma Pharmaceuticals related to ...

The company has announced significant progress in its preclinical studies of Dual Orexin Receptor Agonists (DOXAs), specifically AEX-41 and AEX-2, which are being developed to treat narcolepsy and ...

People with narcolepsy are also more likely to have ADHD. One study found that as many as 30% of people with type 1 narcolepsy (the kind that includes cataplexy, sudden attacks of muscle weakness ...

The Federal Motor Carrier Safety Administration recommends disqualifying individuals with a narcolepsy diagnosis, regardless of treatment. According to 2022 statistics, narcolepsy may put you at a ...